Rare Diseases: Blood Tests

Department of Health and Social Care written question – answered on 29th January 2020.

Alert me about debates like this

Photo of Nickie Aiken Nickie Aiken Conservative, Cities of London and Westminster

To ask the Secretary of State for Health and Social Care, whether he plans to review the criteria for selection of rare diseases to be included in the newborn blood spot test.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

There are no plans to review the UK National Screening Committee’s (UK NSC’s) 20-point criteria for the newborn blood spot test. The newborn blood spot screening programme enables early identification, referral and treatment of babies with nine rare but serious conditions, including sickle cell disease, cystic fibrosis and congenital hypothyroidism.

The UK NSC welcomes proposals to screen for new conditions through its annual call for topics. The call runs from September to December each year and allows members of the public and stakeholders to submit new conditions for the UK NSC to consider and assess against its internationally recognised criteria. It is important that the addition of any new conditions to the newborn blood spot programme is supported by robust peer-reviewed evidence, and that all of our population screening programmes do more good than harm.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.